ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Catalyst-Free Collagen Filament Crosslinking for Engineering Anisotropic and Mechanically Robust Tissue Scaffolds.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Catalyst-Free Collagen Filament Crosslinking for Engineering Anisotropic and Mechanically Robust Tissue Scaffolds.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Engineering mechanically resilient hydrogels from naturally derived proteins, such as collagen and gelatin, remains a key challenge in tissue regeneration, particularly when cell compatibility and structural integrity are simultaneously required. Here, a bioorthogonal crosslinking strategy using rhodamine and polyethylene glycol (PEG) is reported to fabricate dense, mechanically reinforced collagen hydrogels. PEG-mediated dehydration induces spontaneous peptide bond formation between rhodamine and collagen without the need for additional catalysts, yielding fibrous protein networks with enhanced stiffness. To enable anisotropic tissue engineering, this crosslinking method is integrated with wet-spinning to produce uniaxially aligned collagen filaments. These constructs exhibit high mechanical strength and support human adipose-derived stem cell (hASC) encapsulation. Mechanotransductive signaling, including cytoskeletal organization and myogenic gene expression, is effectively activated within the aligned filaments. The applicability of cell-laden filaments in a murine volumetric muscle loss model is demonstrated, which promoted in vitro differentiation and in vivo functional muscle regeneration. This strategy offers a scalable and cytocompatible platform for generating aligned protein-based scaffolds with tunable mechanical and biological properties, thereby expanding the toolkit for regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.